British Study Finds 0.04% Face High Statin Muscle Risk, Builds 6 Million-Patient Prediction Tool
Updated
Updated · NBC News · Jun 25
British Study Finds 0.04% Face High Statin Muscle Risk, Builds 6 Million-Patient Prediction Tool
2 articles · Updated · NBC News · Jun 25
Summary
Nearly 6 million U.K. medical records showed only about 0.04% of adults had a 10-year risk above 10% for serious statin-related muscle disorders, reaffirming that severe side effects are exceptionally rare.
The Lancet Digital Health study also produced a clinician tool to estimate an individual patient’s risk based on factors such as age, lifestyle and other health conditions during treatment decisions.
Statin hesitancy remains widespread despite decades of safety data: fewer than half of roughly 50 million eligible Americans use them, up to one-third never fill prescriptions, and about 40% stop within three months.
Experts said misinformation and anecdotal stories have inflated fears, while the drugs can cut LDL cholesterol by as much as 60% and sharply reduce heart attack and stroke risk.